[{"address1": "116 Huntington Avenue,", "address2": "7th floor", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 892 9080", "website": "https://www.gamida-cell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gamida Cell Ltd. researches, develops, and commercializes cell therapies. The company offers Omisirge (omidubicel-onlv), a cell therapy for use in treatment of patients with hematologic malignancies and severe aplastic anemia. Its product candidate includes GDA-201, an investigational NK cell-based cancer immunotherapy, for the treatment of hematologic and solid tumors, as well as to treat follicular and diffuse large B-cell lymphomas which is in phase 1 of phase1/2 clinical trial. The company was incorporated in 1998 and is based in Boston, Massachusetts.", "fullTimeEmployees": 145, "companyOfficers": [{"maxAge": 1, "name": "Ms. Abigail L. Jenkins M.S.", "age": 47, "title": "President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 685833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Theresa Coelho M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1049098, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronit  Simantov M.D.", "age": 58, "title": "Chief Medical Officer & Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 904680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua F. Patterson", "age": 46, "title": "General Counsel & Chief Compliance Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 832667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda  Stamler", "title": "Vice President of Marketing & Account Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Penny  Bushell", "title": "Chief Human Resource Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naftali  Brikashvili CPA", "title": "Senior Vice President Finance & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tracey  Lodie Ph.D.", "age": 53, "title": "Scientific Advisor & Consultant", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vladimir  Melnikov", "title": "Senior Vice President of Global Operations & Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Heather  DiVecchia", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0173, "open": 0.0172, "dayLow": 0.0156, "dayHigh": 0.0199, "regularMarketPreviousClose": 0.0173, "regularMarketOpen": 0.0172, "regularMarketDayLow": 0.0156, "regularMarketDayHigh": 0.0199, "beta": 0.988, "volume": 638920, "regularMarketVolume": 638920, "averageVolume": 9679340, "averageVolume10days": 3150040, "averageDailyVolume10Day": 3150040, "marketCap": 2545693, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 2.51, "priceToSalesTrailing12Months": 1.426958, "fiftyDayAverage": 0.2424, "twoHundredDayAverage": 0.66105, "currency": "USD", "enterpriseValue": 38934692, "floatShares": 145635149, "sharesOutstanding": 154051008, "sharesShort": 10962800, "sharesShortPriorMonth": 9962348, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.08270001, "heldPercentInsiders": 0.10497, "heldPercentInstitutions": 0.17914, "shortRatio": 6.56, "shortPercentOfFloat": 0.0868, "impliedSharesOutstanding": 154051008, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -62996000, "enterpriseToRevenue": 21.824, "enterpriseToEbitda": -0.551, "52WeekChange": -0.9872612, "SandP52WeekChange": 0.23061275, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "GMDAQ", "underlyingSymbol": "GMDAQ", "shortName": "Gamida Cell Ltd.", "longName": "Gamida Cell Ltd.", "firstTradeDateEpochUtc": 1540560600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "53e2eaff-b98d-3695-b084-16013ed3867c", "messageBoardId": "finmb_556352", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.016525, "targetHighPrice": 6.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 46554000, "totalCashPerShare": 0.302, "ebitda": -70619000, "totalDebt": 82943000, "quickRatio": 1.911, "currentRatio": 2.164, "totalRevenue": 1784000, "revenuePerShare": 0.016, "returnOnAssets": -0.40008998, "freeCashflow": -52019752, "operatingCashflow": -79120000, "grossMargins": -2.10258, "operatingMargins": -14.6021595, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-23"}]